DhruvAS Holding B.V

Over DhruvAS Holding B.V

We support early-phase product development, process validation, and OEM & clinical batch production of synthetic, xenograft, and allograft–derived implantable medical devices for dental, orthopedic, wound care, neurology, and cardiovascular applications. Specifically, Aarna Biomedical has extensive experience & network in the field of use of supercritical CO2 (scCO2) technology for decellularization and sterilization of animal and human tissues as per CE/FDA requirements. We further assists in finding relevant certified partners for assay development, validation, qualitative and quantitative methods, production of OEM and MDM batches under GMP-ISO:13485 -certified cleanroom facilities for clinical trials -to CE/FDA approval for class II and III medical devices. We help entrepreneurs in the decision-making process by methodical analyses of cost price, market analysis, competitive business landscape analysis and business plan writing. We further assist in identifying new business opportunities, term-sheet negotiations, deal making, contracting, and licensing activities with third parties.

For details, reach: 📧 r.siddappa@aarnabiomedical.com 📱 +31 (0) 649 305 041

Adres

• Hoofdkantoor

  2408LZ Alphen aan den RijnZuid-Holland, Nederland

Team per functiegebied

Gebaseerd op 1 openbare functieprofielen, stand van 3 september 2026.

• Other / Unclassifiable1